InfuSystem Holdings INFU Product Sales — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by InfuSystem Holdings in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about InfuSystem Holdings's product sales — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is InfuSystem Holdings's product sales — revenue?
- InfuSystem Holdings (INFU) reported product sales — revenue of $4.01M in Q1 2026.
- How has InfuSystem Holdings's product sales — revenue changed year-over-year?
- InfuSystem Holdings's product sales — revenue decreased by 13.6% year-over-year, from $4.64M to $4.01M.
- What is the long-term trend for InfuSystem Holdings's product sales — revenue?
- Over 4 years (2021 to 2025), InfuSystem Holdings's product sales — revenue has grown at a 2.8% compound annual growth rate (CAGR), from $17.78M to $19.87M.
- What does product sales — revenue mean?
- This metric represents the total net revenue generated from the direct sale of durable medical equipment and related hardware products to healthcare providers or patients. It reflects the company's ability to monetize its product portfolio independently of its service-based offerings. Tracking this revenue stream helps investors assess the scale and growth trajectory of the hardware-focused component of the business model.